(Date:11/24/2009)...loyment grew by 29,000 jobs in October, and the f...h during the U.S. recession. However, clinics and ...systems are coming closer to having to actually cu...s. , (Vocus) November 24,...in October despite the shedding of jobs in most ot...
(Date:11/24/2009)...NODPharmaceuticalsInc.announced,theUSPatent&Tr...r,itsnano-particleoraldeliveryorNODtechnology. ,...poratepeptidesor,proteinsintobio-adhesivenano-part...eredasinjections.NODtechnologyisaplatformtechnolog...nsulin,interferon,growthhormone,exenatide,heparin...
(Date:11/24/2009)...ShanghaiBiolaxyannouncedthe,ChineseStateFood&D...nalnewdrugapplication(IND)foritsoralinsulinproject...betes.ThisIND,approvalallowsBiolaxytoinitiateitsfi...characteristicofhighbloodglucoseandpoor,metabolism...o-and,macro-vasculardiseases,lossofvision,kidneyfa...
(Date:11/24/2009)... approved the Promega PowerPlex 16 HS System for u...DNA records for the National DNA Index System. , ... The FBI recently approved the Promega PowerPlex&...pating in, or generating DNA records for, the Nati...ins more than seven million profiles and has assis...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2...on Net Income increased 118.8% to $2....wswire/ -- China Medicine,Corporation (OTC Bulleti...,a leading distributor and developer of prescripti...al Chinese medicines ("TCM"), nutritional and,diet...ulations in the,People,s Republic of China ("PRC")...
..., Inc.,(OTC Bulletin Board: ACCP) announced today ...ual Noble Financial Equity Conference to be held A...rt, Nevada. Jeffrey B. Davis,CEO of Access is sche...a.m.,Pacific time (12:00 noon Eastern), and will g... product pipeline and technologies., The presenta...
... p.m. CET, AMSTERDAM, August 13 Amsterdam Molecu...field of human gene therapy,today reported its res...s, - Positive results of pivotal trial for Glyber... European patent for treatment of Non-Alcoholic St...henne Muscular Dystrophy from La Sapienza Univers...
Other Biology Technology:China Medicine Announces Strong Second Quarter 2008 Results 2China Medicine Announces Strong Second Quarter 2008 Results 3China Medicine Announces Strong Second Quarter 2008 Results 4China Medicine Announces Strong Second Quarter 2008 Results 5China Medicine Announces Strong Second Quarter 2008 Results 6China Medicine Announces Strong Second Quarter 2008 Results 7China Medicine Announces Strong Second Quarter 2008 Results 8China Medicine Announces Strong Second Quarter 2008 Results 9China Medicine Announces Strong Second Quarter 2008 Results 10China Medicine Announces Strong Second Quarter 2008 Results 11Access Pharmaceuticals to Present at the Noble Financial Equity Conference 2Amsterdam Molecular Therapeutics Reports Half Year Results 2008 2Amsterdam Molecular Therapeutics Reports Half Year Results 2008 3Amsterdam Molecular Therapeutics Reports Half Year Results 2008 4Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-SUR1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-ARG. Vasopressin Polyclonal Antibody, Unconjugated from GeneTex
Pronase Reagent from Biomeda Corporation
Biology Products: